Phase 1, open-label, multicenter study of sovleplenib (HMPL-523) in patients with relapsed or refractory lymphoma

Blood Advances · Elsevier

Аннотация

Publication date: 24 November 2026 Source: Blood Advances, Volume 10, Issue 22 Author(s): Paolo Strati, Dominik Chraniuk, Eva González-Barca, Sairah Ahmed, Caly Chien, Dawn Bongiovanni, Shivani Nanda, William Schelman

Читать у издателя →

Похожие статьи